Table 1.
Variable | Unvaccinated |
Vaccinated |
Susceptible (possibly unvaccinated) |
p | Total |
||||
---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | ||
Total | 76 | 25.3 | 172 | 57.3 | 52 | 17.3 | 300 | 100.0 | |
Age (years) | |||||||||
≤40 | 18 | 17.8 | 65 | 64.4 | 18 | 17.8 | 101 | 33.7 | |
41–50 | 28 | 25.2 | 65 | 58.6 | 18 | 16.2 | 0.118 | 111 | 37.0 |
>50 | 30 | 34.1 | 42 | 47.7 | 16 | 18.2 | 88 | 29.3 | |
Gender | |||||||||
Male | 54 | 30.2 | 102 | 57.0 | 23 | 12.8 | 0.010* | 179 | 59.7 |
Female | 22 | 18.2 | 70 | 57.8 | 29 | 24.0 | 121 | 40.3 | |
Ethnicity | |||||||||
White | 68 | 26.4 | 150 | 58.1 | 40 | 15.5 | 0.104 | 258 | 86.0 |
Black | 8 | 19.0 | 22 | 52.4 | 12 | 28.6 | 42 | 14.0 | |
Highest level of education | |||||||||
<High school | 41 | 23.4 | 96 | 54.9 | 38 | 21.7 | 0.058 | 175 | 58.3 |
≥High school | 35 | 28.0 | 76 | 60.8 | 14 | 11.2 | 125 | 41.7 | |
Monthly income (US$) | |||||||||
<1300 | 49 | 24.4 | 107 | 53.2 | 45 | 22.4 | 0.004* | 201 | 67.0 |
≥1300 | 27 | 27.3 | 65 | 65.7 | 7 | 7.1 | 99 | 33.0 | |
Time since HIV infection diagnosis (years) | |||||||||
<10 | 43 | 26.9 | 96 | 60.0 | 21 | 13.1 | 0.119 | 160 | 53.3 |
≥10 | 33 | 23.6 | 76 | 54.3 | 31 | 22.1 | 140 | 46.7 | |
Time since initiation of antiretroviral therapy (years) | |||||||||
<10 | 48 | 25.5 | 113 | 60.1 | 27 | 14.4 | 0.197 | 188 | 62.7 |
≥10 | 28 | 25.0 | 59 | 52.7 | 25 | 22.3 | 112 | 37.3 | |
Transmission route of HIV infection | |||||||||
Homosexual | 17 | 25.0 | 43 | 63.2 | 8 | 11.8 | 68 | 22.7 | |
Heterosexual | 44 | 23.8 | 106 | 57.3 | 35 | 18.9 | 0.324 | 185 | 61.7 |
Intravenous drug use | 13 | 38.2 | 16 | 47.1 | 5 | 9.6 | 34 | 11.3 | |
Other | 2 | 15.4 | 7 | 53.8 | 4 | 30.8 | 13 | 4.3 | |
HIV viral load (copies/mL) | |||||||||
<50 | 60 | 26.2 | 135 | 59.0 | 34 | 14.8 | 229 | 76.4 | |
50– 10,000 | 9 | 19.6 | 25 | 54.3 | 12 | 26.1 | 0.310 | 46 | 15.3 |
>10,000 | 7 | 28.0 | 12 | 48.0 | 6 | 24.0 | 25 | 8.3 | |
CD4 cell count (cells/μL) | |||||||||
<500 | 38 | 24.8 | 86 | 56.2 | 29 | 19.0 | 0.751 | 153 | 51.0 |
≥500 | 38 | 25.9 | 86 | 58.5 | 23 | 15.6 | 147 | 49.0 |
Statistically significant at p < 0.05.